We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
US Nuclear Corporation (PK) | USOTC:UCLE | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.019 | 26.76% | 0.09 | 0.0781 | 0.09 | 0.0949 | 0.075 | 0.08 | 1,441,681 | 20:47:57 |
July 5, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, DC 20549
RE: US Nuclear Corp.
Registration Statement on Form S-1
File No. 333-265999
To Whom It May Concern:
Please allow this correspondence to serve as an amendment to the Registration Statement on Form S-1 filed by US Nuclear Corp. (the “Company”) with the Securities and Exchange Commission on June 30, 2022. The purpose of this amendment is to include the delaying amendment language required by Rule 473(a) of the Securities Act of 1933, as amended, as follows:
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission acting pursuant to said section 8(a), may determine.
The Company requests that the Staff contact Devin W. Bone, Esq. at (248) 792-6886 or dbone@paalawfirm.com with any questions or comments.
US NUCLEAR CORP. | |||
/s/ Robert I. Goldstein | |||
Robert I. Goldstein | |||
President and CEO |
1 Year US Nuclear (PK) Chart |
1 Month US Nuclear (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions